chartexchange

Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026

PR Newswire | Oct 21, 2026 4:05 PM EDT

NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Nuvation Bio Inc. ("Nuvation Bio") (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced it will host a conference call and webcast on Wednesday, November 4, 2026, at 4:30...

Read original article